1.McIntyre L, Huertas F, Morse A, Kaletsky R, Murphy C, Kalia V, Miller G, Moskalenko O, Conesa A, Mor D. GAIT-GM integrative cross-omics analyses reveal cholinergic defects in a C. elegans model of Parkinson’s disease. Sci Rep. 2022;12(1):3268. PMCID: PMC8885929 Reference Link
1.Sohrabi S, Mor D, Kaletsky R, Keyes W, Murphy C. High-throughput behavioral screen in C. elegans reveals Parkinson’s disease drug candidates. Commun Biol. 2021;4(1):203. PMCID: PMC7884385 Reference Link
1.Mor D, Murphy C. Mitochondrial hyperactivity as a potential therapeutic target in Parkinson’s disease. Transl Med Aging. 2020;4:117–120. PMCID: PMC7653964 Reference Link
1.Mor D, Sohrabi S, Kaletsky R, Keyes W, Tartici A, Kalia V, Miller G, Murphy C. Metformin rescues Parkinson’s disease phenotypes caused by hyperactive mitochondria. Proc Natl Acad Sci U S A. 2020;117(42):26438–26447. PMCID: PMC7585014 Reference Link
1.Yao V, Kaletsky R, Keyes W, Mor D, Wong A, Sohrabi S, Murphy C, Troyanskaya O. An integrative tissue-network approach to identify and test human disease genes. Nat Biotechnol. 2018;. PMCID: PMC7021177 Reference Link
